Financing equitable access to antiretroviral treatment in South Africa
- PMID: 20594368
- PMCID: PMC2895746
- DOI: 10.1186/1472-6963-10-S1-S2
Financing equitable access to antiretroviral treatment in South Africa
Abstract
Background: While South Africa spends approximately 7.4% of GDP on healthcare, only 43% of these funds are spent in the public system, which is tasked with the provision of care to the majority of the population including a large proportion of those in need of antiretroviral treatment (ART). South Africa is currently debating the introduction of a National Health Insurance (NHI) system. Because such a universal health system could mean increased public healthcare funding and improved access to human resources, it could improve the sustainability of ART provision. This paper considers the minimum resources that would be required to achieve the proposed universal health system and contrasts these with the costs of scaled up access to ART between 2010 and 2020.
Methods: The costs of ART and universal coverage (UC) are assessed through multiplying unit costs, utilization and estimates of the population in need during each year of the planning cycle. Costs are from the provider's perspective reflected in real 2007 prices.
Results: The annual costs of providing ART increase from US$1 billion in 2010 to US$3.6 billion in 2020. If increases in funding to public healthcare only keep pace with projected real GDP growth, then close to 30% of these resources would be required for ART by 2020. However, an increase in the public healthcare resource envelope from 3.2% to 5%-6% of GDP would be sufficient to finance both ART and other services under a universal system (if based on a largely public sector model) and the annual costs of ART would not exceed 15% of the universal health system budget.
Conclusions: Responding to the HIV-epidemic is one of the many challenges currently facing South Africa. Whether this response becomes a "resource for democracy" or whether it undermines social cohesiveness within poor communities and between rich and poor communities will be partially determined by the steps that are taken during the next ten years. While the introduction of a universal system will be complex, it could generate a health system responsive to the needs of all South Africans.
Similar articles
-
The role of insurance in the achievement of universal coverage within a developing country context: South Africa as a case study.BMC Public Health. 2012;12 Suppl 1(Suppl 1):S5. doi: 10.1186/1471-2458-12-S1-S5. Epub 2012 Jun 22. BMC Public Health. 2012. PMID: 22992410 Free PMC article.
-
Human resources for treating HIV/AIDS: needs, capacities, and gaps.AIDS Patient Care STDS. 2007 Nov;21(11):799-812. doi: 10.1089/apc.2007.0193. AIDS Patient Care STDS. 2007. PMID: 17944556
-
The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.PLoS Med. 2015 Nov 24;12(11):e1001907; discussion e1001907. doi: 10.1371/journal.pmed.1001907. eCollection 2015 Nov. PLoS Med. 2015. PMID: 26599990 Free PMC article.
-
Access to antiretroviral treatment in developing countries: Which financing strategies are possible?Rev Epidemiol Sante Publique. 2010 Jun;58(3):171-9. doi: 10.1016/j.respe.2010.03.002. Epub 2010 Apr 28. Rev Epidemiol Sante Publique. 2010. PMID: 20430553 Review.
-
Implementing 'universal' access to antiretroviral treatment in South Africa: a scoping review on research priorities.Health Policy Plan. 2021 Jun 25;36(6):923-938. doi: 10.1093/heapol/czaa094. Health Policy Plan. 2021. PMID: 33963393 Free PMC article.
Cited by
-
The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis.PLoS Med. 2015 Sep 1;12(9):e1001869. doi: 10.1371/journal.pmed.1001869. eCollection 2015 Sep. PLoS Med. 2015. PMID: 26327271 Free PMC article.
-
Antibody-mediated depletion of viral reservoirs is limited in SIV-infected macaques treated early with antiretroviral therapy.J Clin Invest. 2021 Mar 15;131(6):e142421. doi: 10.1172/JCI142421. J Clin Invest. 2021. PMID: 33465055 Free PMC article.
-
Scaling up health policies and services in low- and middle-income settings.BMC Health Serv Res. 2010 Jul 2;10 Suppl 1(Suppl 1):I1. doi: 10.1186/1472-6963-10-S1-I1. BMC Health Serv Res. 2010. PMID: 20594366 Free PMC article.
-
Elevated Plasma Viral Loads in Romidepsin-Treated Simian Immunodeficiency Virus-Infected Rhesus Macaques on Suppressive Combination Antiretroviral Therapy.Antimicrob Agents Chemother. 2015 Dec 28;60(3):1560-72. doi: 10.1128/AAC.02625-15. Antimicrob Agents Chemother. 2015. PMID: 26711758 Free PMC article.
-
Social exposure to an antiretroviral treatment programme in rural KwaZulu-Natal.Trop Med Int Health. 2011 Aug;16(8):988-94. doi: 10.1111/j.1365-3156.2011.02795.x. Epub 2011 May 26. Trop Med Int Health. 2011. PMID: 21615631 Free PMC article.
References
-
- UNAIDS. AIDS epidemic update: December 2007. Joint United Nations Programme on HIV/AIDS and World Health Organisation. 2007.
-
- HIV & AIDS and STI National Strategic Plan 2007-2011. Pretoria: South African National AIDS Council (SANAC) 2007. pp. 1–136.
-
- National Antiretroviral Treatment Guidelines. Pretoria: National Department of Health. 2004.
-
- Hogan B. Minister of Health's closing speech to the 4th SA AIDS Conference. Southern African AIDS Conference: 2009; Durban. 2009.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical